Urology is emerging as an increasingly attractive specialty for private equity consolidation. The combination of an aging patient population, growing procedural capabilities in the office setting, and fragmented market structure creates the conditions PE buyers seek for platform-building opportunities.
If you're considering selling your urology practice, understanding what drives valuations in this specialty—and how to position your practice for maximum value—is essential for a successful exit.
Urology Valuation Snapshot
Urology practices typically sell for 4-6x EBITDA, with premium valuations going to groups with strong in-office procedure capabilities, ancillary services (imaging, lab, pathology), and multi-location footprints. Practices with high surgical volume and ASC ownership command the top of the range.
Why PE Is Interested in Urology
Private equity interest in urology has grown significantly in recent years, driven by several factors:
1. Demographic Tailwinds
Urology's patient population skews older, with many conditions (BPH, prostate cancer, kidney stones, incontinence) increasing with age. As America's population ages, demand for urological services is growing predictably and significantly.
2. In-Office Procedure Migration
Many procedures that previously required hospital settings are now performed in the office or ASC:
- Rezūm and UroLift BPH treatments in office
- Cystoscopy Diagnostic and therapeutic
- Lithotripsy Kidney stone treatment
- Prostate biopsies Fusion biopsies in office
- Vasectomy High-volume office procedure
This shift creates margin opportunity that buyers can capture and expand across platforms.
3. Ancillary Revenue Opportunities
Urology practices can capture multiple ancillary revenue streams:
- In-house pathology (prostate cores)
- Advanced imaging (CT, ultrasound)
- Radiation oncology partnerships
- Dispensary (testosterone, ED medications)
- Clinical research
4. Fragmented Market
Most urology practices remain independently owned, creating a classic roll-up opportunity for PE platforms to consolidate, centralize operations, and achieve scale.
| Practice Profile | Typical Multiple | Key Value Drivers |
|---|---|---|
| Solo General Urology | 3-4x EBITDA | Patient volume, referral relationships |
| Multi-MD Group | 4-5.5x EBITDA | Scale, subspecialty coverage, management depth |
| Group with Strong Ancillaries | 5-6x EBITDA | In-house path, imaging, dispensary, procedures |
| Group with ASC Ownership | 5.5-7x EBITDA | Surgery center economics, surgical volume |
Who's Buying Urology Practices?
Urology-Focused PE Platforms
Several PE-backed platforms are now specifically focused on urology consolidation, including Solaris Health and regional players. These buyers typically offer:
- Highest valuations for practices meeting their criteria
- Cash at close plus rollover equity (typically 20-35%)
- Centralized support (billing, IT, HR)
- Capital for ancillary development
- Employment agreements (3-5 years)
Multi-Specialty Platforms
Some broader physician services platforms include urology in their acquisition strategy, particularly when combined with other surgical specialties.
Health Systems
Hospital systems continue to acquire urology practices for service line development and surgical volume capture, typically at 3-5x EBITDA.
The Ancillary Advantage
Practices with established ancillary services (particularly in-house pathology for prostate specimens) often command 1-2x EBITDA higher valuations. If you're 2-3 years from exit, developing ancillary capabilities may provide significant ROI.
What Buyers Look For in Urology Practices
Premium Indicators
- Multiple urologists 3+ physicians reduces key-person risk
- Strong in-office procedure mix High adoption of office-based procedures
- In-house ancillaries Pathology, imaging, dispensary
- ASC ownership or access Surgical economics captured
- Subspecialty depth Oncology, female urology, pediatric
- Modern technology Robotic surgery capability, fusion biopsy
- Growth trajectory Increasing volume and revenue trends
Value Detractors
- Solo practice Key-person risk limits valuation
- Hospital-dependent surgery No ASC economics
- Limited ancillary development Missed revenue capture
- Aging physician approaching burnout Declining production
- Rural location Harder to recruit and limited payer mix
Preparing Your Urology Practice for Sale
- Develop ancillary services In-house pathology, imaging, and dispensary add value
- Optimize in-office procedures Maximize office-based procedural revenue
- Document referral relationships Primary care and specialist referral patterns
- Build management depth Reduce owner-dependence for operations
- Lock in key staff Retention agreements for critical team members
- Clean up compliance Stark, anti-kickback, and billing compliance
What's Your Urology Practice Worth?
Our valuation calculator uses specialty-specific multiples to give you an instant estimate based on your revenue, EBITDA, and practice characteristics.
Request Confidential ValuationTimeline for Urology Practice Sales
| Phase | Duration | Key Activities |
|---|---|---|
| Pre-Sale Preparation | 12-24 months | Develop ancillaries, optimize procedures, build management |
| Advisor Engagement | 1-2 months | Select representation, prepare marketing materials |
| Market Process | 2-4 months | Buyer outreach, management presentations |
| Due Diligence | 60-90 days | Financial review, compliance, QofE |
| Documentation & Close | 30-45 days | Purchase agreement, employment contracts |
Next Steps
- Get a realistic valuation Understand what buyers will pay for your practice
- Assess your ancillary development What revenue streams could you add?
- Evaluate your timeline Are you ready now, or should you build value first?
- Consider your post-sale goals Maximum proceeds vs. optimal employment terms?
Start With Your Valuation
The first step in any exit is understanding your practice's market value. Get a confidential estimate.
Calculate My Practice ValueRelated Resources
- Medical Practice for Sale: Complete seller's guide
- Selling to Private Equity: How PE deals work
- Medical Practice Valuation: Understanding EBITDA and multiples
- ASC Valuation Guide: Surgery center economics